← Comparing 2 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
eIF2α Phosphorylation Imbalance Disrupts Mitochondrial Prote (EIF2S1,eIF2α,PERK,GCN2,ATF4,TOMM20,TIMM23,NDUFS1,NDUFS3,COX4I1,COX5A,mitochondrial protein import) — 0.00 Closed-loop transcranial focused ultrasound to restore hippo (SST) — 0.00 LDLR-Primed LRP1 Transcytosis with pH-Responsive Escape Stra (LDLR) — 0.00 GLUT1-Mediated Carrier-Conjugate Delivery Strategy (LDLR) — 0.00 TBK1 Loss Triggers Astrocyte-to-Neuron Senescence Propagatio (TBK1 → NF-κB / IRF3 / p62-autophagy / SASP effectors) — 0.00 LDLR-Mediated Neurosteroid Precursor Delivery Strategy (LDLR) — 0.00 Alpha-theta entrainment therapy to enhance default mode netw (SST) — 0.00 LAMP2A Upregulation to Enhance Chaperone-Mediated Autophagy (LAMP2A) — 0.00 TBK1 Loss Triggers eIF2α-Mediated Translational Repression T (TBK1, EIF2S1) — 0.00 LAMP1 Overexpression to Enhance Lysosomal Capacity Independe (LAMP1) — 0.00 Cell-Type-Specific TFEB Modulation Combined with Trehalose f (TFEB) — 0.00 Closed-loop transcranial focused ultrasound with gamma entra (PVALB) — 0.00 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.97 GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl (GRIN2B) — 0.96 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.96 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.96 Cortico-Striatal Synchrony Restoration via NMDA Modulation (GRIN2B) — 0.95 Gamma entrainment therapy to restore hippocampal-cortical sy (SST) — 0.95 Plasma NfL Elevation Secondary to BBB-Associated Transport D (NEFL) — 0.94 Microglial-Mediated Tau Clearance Dysfunction via TREM2 Rece (MAPT) — 0.94 Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming (NLRP3, CASP1, IL1B, PYCARD) — 0.92 Closed-loop transcranial focused ultrasound to restore hippo (CCK) — 0.91 eIF2α Phosphorylation Imbalance Creates Integrated Stress Re (EIF2S1,eIF2α,PERK,GCN2,ATF4,ATF5,CHOP,DDIT3,integrated stress response,protein synthesis) — 0.90 APOE-Dependent Autophagy Restoration (MTOR) — 0.89 Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Colla (SLC16A1, SLC16A7, LDHA, PDHA1) — 0.89 p38α Inhibitor and PRMT1 Activator Combination to Restore Ph (MAPK14/PRMT1) — 0.89 SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc (SIRT1) — 0.89 TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener (TREM2) — 0.89 ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro (ACSL4) — 0.89 Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa (APP/PSEN1 (Aβ production), CHAT (cholinergic synthesis)) — 0.89
Add
|
× CSF1R Agonism for TREM2-I × LAMP2A-Mediated Autophagy
CSF1R · neurodegeneration · -
Composite 0.445
Price $0.48
Evidence For 0
Evidence Against 0
Proposed CSF1R agonism to activate neuroprotective microglial states avoiding TREM2-dependent inflammation. Fatal mechanistic flaw—cited evidence describes CSF1R antagonist (PLX5622) effects, contradicting agonist strategy. Not developable as stated; requires complete reformulation.
LAMP2A · neurodegeneration · -
Composite 0.745
Price $0.64
Evidence For 0
Evidence Against 0
AAV9-mediated overexpression of LAMP2A enhances chaperone-mediated autophagy to selectively degrade pathological alpha-synuclein species, preventing Lewy body formation and blocking cell-to-cell propagation. Strongest mechanistic foundation with validated AAV platform and clear patient stratification via seed amplification assays.
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
Autophagy Unspecified Mechanism neurodegeneration
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary 1/11
dimensions won
CSF1R Agonism for TREM2-Independent Micr
11/11
dimensions won
LAMP2A-Mediated Autophagy Enhancement Bl
Radar Chart — 10 Dimensions
Score Breakdown
Dimension CSF1R Agonism for TREM2-Indepe LAMP2A-Mediated Autophagy Enha Mechanistic 0.350 0.800 Evidence 0.300 0.750 Novelty 0.500 0.700 Feasibility 0.250 0.750 Impact 0.400 0.800 Druggability 0.450 0.700 Safety 0.400 0.650 Competition 0.550 0.750 Data 0.650 0.800 Reproducible 0.600 0.750 KG Connect 0.500 0.500
Evidence CSF1R Agonism for TREM2-Independent Microglial Activation in No evidence citations yet
LAMP2A-Mediated Autophagy Enhancement Blocks Alpha-Synuclein No evidence citations yet
Debate Excerpts CSF1R Agonism for TREM2-Independent Microglial Act 4 rounds · quality: 0.74
Persona-Theorist # Therapeutic Hypotheses in Neurodegeneration
---
## Hypothesis 1: TREM2-Independent Microglial Activation via CSF1R Agonism for Amyotrophic Lateral Sclerosis
**Mechanism:** CSF1R (colony-stimulati...
Persona-Skeptic # Critical Evaluation of Neurodegeneration Therapeutic Hypotheses
## Hypothesis 1: CSF1R Agonism for ALS
**Weak Links:**
- **Critical logical inconsistency:** The cited evidence (PMID: 30327527) des...
Persona-Domain Expert # Domain Expert Feasibility Assessment: Neurodegeneration Therapeutic Hypotheses
---
## Hypothesis 3: LAMP2A Enhancement for PD (Revised Confidence: 0.62)
### Druggability
**Modality:** AAV9-mediat...
Persona-Synthesizer ```json
{
"ranked_hypotheses": [
{
"title": "LAMP2A-Mediated Autophagy Enhancement Blocks Alpha-Synuclein Propagation in Parkinson's Disease",
"description": "AAV9-mediated overexpre...
LAMP2A-Mediated Autophagy Enhancement Blocks Alpha 4 rounds · quality: 0.74
Persona-Theorist # Therapeutic Hypotheses in Neurodegeneration
---
## Hypothesis 1: TREM2-Independent Microglial Activation via CSF1R Agonism for Amyotrophic Lateral Sclerosis
**Mechanism:** CSF1R (colony-stimulati...
Persona-Skeptic # Critical Evaluation of Neurodegeneration Therapeutic Hypotheses
## Hypothesis 1: CSF1R Agonism for ALS
**Weak Links:**
- **Critical logical inconsistency:** The cited evidence (PMID: 30327527) des...
Persona-Domain Expert # Domain Expert Feasibility Assessment: Neurodegeneration Therapeutic Hypotheses
---
## Hypothesis 3: LAMP2A Enhancement for PD (Revised Confidence: 0.62)
### Druggability
**Modality:** AAV9-mediat...
Persona-Synthesizer ```json
{
"ranked_hypotheses": [
{
"title": "LAMP2A-Mediated Autophagy Enhancement Blocks Alpha-Synuclein Propagation in Parkinson's Disease",
"description": "AAV9-mediated overexpre...
Price History Overlay